Stocks News

LAST PRICE
10.4500
TODAY'S CHANGE (%)
Trending Up0.4900 (4.9197%)

Bid / Lots
10.5200/ 8
Ask / Lots
11.5000/ 5
Open / Previous Close
9.5500 / 9.9600
Day Range
Low 9.0001
High 10.5300
52 Week Range
Low 6.8802
High 16.6300
Volume
760,377
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 8, 2024
- DJ 89bio Is Maintained at Strong Buy by Raymond James, from 12:45PM ET on Friday Nov 08, 2024 by Dow Jones
  12:45PM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: ETNB
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/ETNB/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 08, 2024 12:45 ET (17:45 GMT)
Nov 7, 2024
- Press Release: 89bio Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ETNB
  
  Annie Chang
  
  89bio, Inc.
  
  annie.chang@89bio.com
  
  PJ Kelleher
  
  LifeSci Advisors, LLC
  
  +1-617-430-7579
- 89bio Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  4:05PM ET on Thursday Nov 07, 2024 by Dow Jones
  Companies Mentioned: ETNB
  
  Annie Chang
  
  89bio, Inc.
  
  annie.chang@89bio.com
  
  PJ Kelleher
  
  LifeSci Advisors, LLC
  
  +1-617-430-7579
Nov 5, 2024
- 89bio to Participate in the UBS Global Healthcare Conference, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
  4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: ETNB
  
  89bio to Participate in the UBS Global Healthcare Conference
  
  SAN FRANCISCO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the "Company" or "89bio") (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company's Management will participate in a fireside chat at the UBS Global Healthcare Conference on Tuesday, November 12, 2024 at 12:30 PM EST and participate in one-on-one investor meetings.
Oct 15, 2024
- 89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting(R) 2024, from 8:30AM ET on Tuesday Oct 15, 2024 by Dow Jones
  8:30AM ET on Tuesday Oct 15, 2024 by Dow Jones
  Companies Mentioned: ETNB
  
  investors@89bio.com
  
  PJ Kelleher
  
  LifeSci Advisors, LLC
  
  +1-617-430-7579
  
  pkelleher@lifesciadvisors.com
  
  Media Contact:

Nov 5, 2024
- Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting, from 9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: COGT
Nov 4, 2024
- DJ Cogent Biosciences Price Target Maintained With a $17.00/Share by HC Wainwright & Co., from 6:58AM ET on Monday Nov 04, 2024 by Dow Jones
  6:58AM ET on Monday Nov 04, 2024 by Dow Jones
  Companies Mentioned: COGT
Oct 30, 2024
- Press Release: Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering, from 4:41PM ET on Wednesday Oct 30, 2024 by Dow Jones
  4:41PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: SEPN
- Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering, from 4:41PM ET on Wednesday Oct 30, 2024 by Dow Jones
  4:41PM ET on Wednesday Oct 30, 2024 by Dow Jones
  Companies Mentioned: SEPN
Oct 25, 2024
- DJ Septerna Shares Rise 29% on First Trading Day, from 2:55PM ET on Friday Oct 25, 2024 by Dow Jones
  2:55PM ET on Friday Oct 25, 2024 by Dow Jones
  Companies Mentioned: SEPN
- Septerna Prices $288 Million Initial Public Offering, from 4:00AM ET on Friday Oct 25, 2024 by MT Newswires
  4:00AM ET on Friday Oct 25, 2024 by MT Newswires
Oct 24, 2024
- DJ Cogent Biosciences Price Target Maintained With a $16.00/Share by Needham, from 6:08AM ET on Thursday Oct 24, 2024 by Dow Jones
  6:08AM ET on Thursday Oct 24, 2024 by Dow Jones
  Companies Mentioned: COGT
Oct 23, 2024
- Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics, from 7:00AM ET on Wednesday Oct 23, 2024 by Dow Jones
  7:00AM ET on Wednesday Oct 23, 2024 by Dow Jones
  Companies Mentioned: COGT

89Bio Inc
NASDAQ:ETNBUnited States

Search Criteria

Nov 8, 2024

DJ 89bio Is Maintained at Strong Buy by Raymond James, from 12:45PM ET on Friday Nov 08, 2024 by Dow Jones

Nov 7, 2024

Press Release: 89bio Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

89bio Reports Third Quarter 2024 Financial Results and Corporate Updates, from 4:05PM ET on Thursday Nov 07, 2024 by Dow Jones

Nov 5, 2024

89bio to Participate in the UBS Global Healthcare Conference, from 4:05PM ET on Tuesday Nov 05, 2024 by Dow Jones

Oct 15, 2024

89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting(R) 2024, from 8:30AM ET on Tuesday Oct 15, 2024 by Dow Jones

Peers Headlines

Nov 5, 2024

Cogent Biosciences Announces Bezuclastinib Presentations at the 66th Annual American Society of Hematology (ASH) Meeting, from 9:00AM ET on Tuesday Nov 05, 2024 by Dow Jones

Nov 4, 2024

DJ Cogent Biosciences Price Target Maintained With a $17.00/Share by HC Wainwright & Co., from 6:58AM ET on Monday Nov 04, 2024 by Dow Jones

Oct 30, 2024

Press Release: Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering, from 4:41PM ET on Wednesday Oct 30, 2024 by Dow Jones

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering, from 4:41PM ET on Wednesday Oct 30, 2024 by Dow Jones

Oct 25, 2024

DJ Septerna Shares Rise 29% on First Trading Day, from 2:55PM ET on Friday Oct 25, 2024 by Dow Jones

Septerna Prices $288 Million Initial Public Offering, from 4:00AM ET on Friday Oct 25, 2024 by MT Newswires

Oct 24, 2024

DJ Cogent Biosciences Price Target Maintained With a $16.00/Share by Needham, from 6:08AM ET on Thursday Oct 24, 2024 by Dow Jones

Oct 23, 2024

Cogent Biosciences Announces Pipeline Expansion into KRAS and Poster Presentations at the 2024 EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics, from 7:00AM ET on Wednesday Oct 23, 2024 by Dow Jones